The Apple Watch packs a bunch of features into an incredibly tiny package, boasting seemingly magical capabilities like ECG results and A-Fib detection. One of the health features it doesn't have at ...
Sugar can lead to high blood sugar and contributes to the development of diabetes. Monitoring blood sugar is a crucial part of managing diabetes. You'll want the best device to regularly check your ...
Blood glucose monitoring systems (BGMS) have become an integral component in the management of diabetes, providing patients and clinicians with essential real‐time information to guide treatment ...
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
The U.S. Food and Drug Administration has cleared the Nova StatStrip Glucose Hospital Meter System for use with critically ill patients, making it the first blood glucose monitoring system approved ...
The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, including weight management support. The device offers real-time glucose tracking ...
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose ...
Introduced in the late 1990s, continuous glucose monitoring (CGM) revolutionized diabetes care. Prior to CGM, home blood glucose monitoring (BGM) methodologies – which involve patients using a lancet ...
Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...